PEX12 antibody (Middle Region)
Quick Overview for PEX12 antibody (Middle Region) (ABIN954095)
Target
See all PEX12 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 137-167, Middle Region
-
Specificity
- This antibody recognizes Human and Mouse Peroxin 12 / PEX12 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 137~167 amino acids from the Central region of human PEX12
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PEX12 (Peroxisomal Biogenesis Factor 12 (PEX12))
-
Alternative Name
- Peroxin 12 / PEX12
-
Background
- Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle.Synonyms: PAF-3, PAF3, Peroxin-12, Peroxisome assembly factor 3, Peroxisome assembly protein 12
-
Molecular Weight
- 40797 Da
-
Gene ID
- 5193
-
NCBI Accession
- NP_000277
Target
-